在胰腺癌模型中,MAP4K2通过促进Treg分化来抑制抗瘤免疫力
相关实验视频
Updated: Feb 1, 2026

An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
Huai-Chia Chuang1, Chia-Wen Wang1, Chia-Hsin Hsueh1
1Immunology Research Center, National Health Research Institutes, Zhunan, Taiwan.
MAP4K2通过与DDX39B相互作用,促进调节性T细胞 (Treg) 分化,增强免疫反应. 这一发现对于了解自身免疫性疾病和改进癌症免疫治疗至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 马普激酶 (MAP4K) 家族的激酶对T细胞免疫非常重要.
- 在免疫调节中MAP4K2的特定体内作用尚未完全理解.
研究的目的:
- 阐明MAP4K2在免疫调节中的体内功能.
- 研究MAP4K2影响T调控细胞 (Treg) 差异化的机制.
主要方法:
- 使用了T细胞特异性MAP4k2条件淘汰 (T-Map4k2 cKO) 的小鼠.
- 采用单细胞RNA测序 (scRNA-seq) 和质谱学.
- 研究了蛋白质相互作用和酸化事件.
主要成果:
- MAP4K2与DDX39B相互作用,并促进分叉盒蛋白P3 (FOXP3) 基因表达,驱动Treg分化.
- MAP4K2直接酸化DDX39B,促进其核转移和随后的FOXP3RNA拼接.
- T-Map4k2 cKO小鼠显示Treg种群减少,在EAE模型中持续炎症,并增强了胰腺癌抗PD-1免疫疗法的疗效.
结论:
- MAP4K2是通过DDX39B通路对Treg分化的关键调节者.
- 抑制或缺乏MAP4K2可以减弱Treg介导的抑制,改善抗瘤免疫力.
- 胰腺癌患者瘤透Treg细胞中MAP4K2水平升高表明其具有临床意义.
更多相关视频
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
14:01Human In Vitro Suppression as Screening Tool for the Recognition of an Early State of Immune Imbalance
Published on: July 22, 2011
相关概念视频
The Eukaryotic Promoter Region
The Eukaryotic Promoter Region
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...
Models of Health Promotion and Illness Prevention I
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
Humoral Immune Responses
Modeling with Differential Equations